Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-05-16

Opinion for Johnson & Johnson (JNJ-N)

Signal Price Bias Subject Owned
TOP PICK $127.770 BULLISH NORTH AMERICAN - LARGE Yes

A large, global, pharmaceutical company. The primary reason she likes this is that their pharma division is doing really, really well. They’ve had a very successful 5 years, and suspects they have a strong enough pipeline to keep that growth going. Recently acquired a Swiss pharmaceutical company which has leading products in heart disease. AAA balance sheet. Dividend yield of 2.7%. (Analysts’ price target is $130.)

Christine Poole
CEO & Managing Director, GlobeInvest Capital Management

No Comments.


You must be logged in to comment.